Andere Kunden interessierten sich auch für
![Advancing Gene-Targeted Therapies for Central Nervous System Disorders]( "Advancing Gene-Targeted Therapies for Central Nervous System Disorders")
Advancing Gene-Targeted Therapies for Central Nervous System Disorders73,99 €![Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders]( "Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders")
Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders62,99 €![Investing in Interventions That Address Non-Medical, Health-Related Social Needs]( "Investing in Interventions That Address Non-Medical, Health-Related Social Needs")
Investing in Interventions That Address Non-Medical, Health-Related Social Needs54,99 €![Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood-Brain Barrier]( "Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood-Brain Barrier")
Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood-Brain Barrier62,99 €![Harnessing Mobile Devices for Nervous System Disorders]( "Harnessing Mobile Devices for Nervous System Disorders")
Harnessing Mobile Devices for Nervous System Disorders65,99 €![Exploring the Adoption of Implantable Brain Stimulation Into Standard of Care for Central Nervous System Disorders]( "Exploring the Adoption of Implantable Brain Stimulation Into Standard of Care for Central Nervous System Disorders")
Exploring the Adoption of Implantable Brain Stimulation Into Standard of Care for Central Nervous System Disorders25,99 €![Promoting Health Literacy to Encourage Prevention and Wellness]( "Promoting Health Literacy to Encourage Prevention and Wellness")
Promoting Health Literacy to Encourage Prevention and Wellness40,99 €
The Institute of Medicine (IOM) Forum on Neuroscience and Nervous System Disorders, in collaboration with the IOM Forum on Drug Discovery, Development, and Translation, convened a workshop on January 20-21, 2015, to explore policy changes that might increase private sector investment in research and development innovation that fills unmet medical needs for central nervous system (CNS) disorders. Workshop participants strategized about how to incentivize companies to fortify their CNS drug development programs, shrinking obstacles that currently deter ventures. Representatives from academia, government agencies, patient groups, and industry gathered to share information and viewpoints, and to brainstorm about budget-neutral policy changes that could help widen the pipeline toward drugs that address unmet needs for CNS disorders. This report summarizes the presentations and discussion of the workshop.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.